January 30, 2023
International Business Times
Paxlovid Sales Forecasts May Change With Pfizer View On China
Clarity from Pfizer Inc this week on whether China's relaxation of its Zero-COVID policy and the surg... See more »
Active Biotech: Active Biotech strengthens the patent protection for laquinimod in eye disorders
Lund, April 26, 2022, Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the European Patent Office (EPO) has issued a decision to grant Active Biotech's patent related to use of laquini...
Read full article »
January 30, 2023
Pharamceutical Technology
Lilly's Jaypirca received FDA approval to treat MCL
Jaypirca is indicated to treat relapsed or refractory MCL in adults, who had at least two lines of sy... See more »
January 30, 2023
International Business Times
Paxlovid Sales Forecasts May Change With Pfizer View On China
Clarity from Pfizer Inc this week on whether China's relaxation of its Zero-COVID policy and the surg... See more »
January 30, 2023
Pharamceutical Technology
Lilly's Jaypirca received FDA approval to treat MCL
Jaypirca is indicated to treat relapsed or refractory MCL in adults, who had at least two lines of sy... See more »
President & CEO
Tomas Leanderson
Active Biotech focuses on developing pharmaceuticals products for immune defense.
Read more